Guideline 8.4 — Neonatal Meningitis

BEDSIDE ACTION BOX

Suspect meningitis in any septic neonate — especially with a bulging fontanelle, seizures, altered consciousness, or a positive blood culture; presentation is often non-specific.
Perform a lumbar puncture when meningitis is suspected or a blood culture is positive — but do not delay antibiotics in a sick baby (give first, LP as soon as safe).
Blood cultures can be negative in proven meningitis — a normal blood culture does not exclude it; the CSF is decisive.
Use CSF-penetrating, meningitic-dose antibiotics (empirically per local policy; e.g., a third-generation cephalosporin plus amoxicillin/ampicillin for Listeria, ± an aminoglycoside), and treat for a longer duration than uncomplicated sepsis.
Repeat the LP to document CSF sterilization where indicated, and image the brain for complications (ventriculitis, abscess, hydrocephalus, infarction).

1. Overview

Overview

Neonatal meningitis is inflammation of the meninges from bacterial (or occasionally viral/fungal) infection, often complicating early- or late-onset sepsis. It carries high risks of death and neurological sequelae, and its management differs from uncomplicated sepsis: it requires CSF confirmation by lumbar puncture, antibiotics that penetrate the central nervous system at meningitic doses, longer treatment durations, and imaging for complications.

Why This Topic Matters

Missed or under-treated meningitis causes preventable death and disability (hearing loss, cerebral palsy, hydrocephalus). Getting the LP done, choosing the right drug and dose, treating long enough, and detecting complications are decisive.

2. Who This Guideline Applies To

Scope

Neonates with suspected/confirmed meningitis, or with sepsis and a positive blood culture or CNS signs.
Infants requiring CSF-directed treatment and complication surveillance.
Cross-references: early-onset sepsis (8.1), late-onset sepsis (8.2), seizures (9.3), IVH/hydrocephalus (9.2), and congenital infections (8.3).

3. Key Definitions

Term	Definition
Neonatal meningitis	Meningeal infection in the first month (bacterial, sometimes viral/fungal).
Ventriculitis	Ventricular inflammation — associated with worse outcome; may need prolonged therapy.
Meningitic dosing	Higher antibiotic doses to achieve CNS therapeutic levels.
CSF sterilization	Documented clearance of the organism from CSF (repeat LP).

4. Organisms

Timing	Typical organisms
Early-onset	Group B streptococcus, E. coli (and other Gram-negatives), Listeria monocytogenes.
Late-onset/hospital-acquired	Gram-negatives, coagulase-negative staphylococci, Staph. aureus, enterococci; Candida (fungal).
Viral	Herpes simplex virus (consider aciclovir — see 8.3), enteroviruses.

5. Presentation

Often Non-Specific

Signs of sepsis (temperature instability, poor feeding, lethargy/irritability, apnea, respiratory distress).
More specific CNS signs: bulging/full fontanelle, seizures, altered tone/consciousness, high-pitched cry, opisthotonus (late).
Classic "neck stiffness" is usually absent in neonates — do not rely on it.

6. Lumbar Puncture

Confirm with CSF

Do an LP when meningitis is suspected or a blood culture is positive; send CSF for cell count, protein, glucose (with paired plasma glucose), Gram stain, culture, and PCR (including HSV/enterovirus where indicated).
Do not delay antibiotics for the LP in a sick infant — treat first, LP as soon as safe; defer LP if the infant is unstable or has contraindications, and interpret partially-treated CSF with care.
A negative blood culture does not exclude meningitis — the CSF is decisive.

7. Management Algorithm

Suspect meningitis

Septic neonate, CNS signs, or positive blood culture → plan LP and CNS-directed treatment.

Start CNS-penetrating antibiotics promptly

Do not delay for LP in a sick baby; use meningitic doses per policy; add aciclovir if HSV suspected.

Perform LP & investigate

CSF cell count/protein/glucose/Gram/culture/PCR; blood cultures; correlate — CSF is decisive.

Tailor & treat longer

Adjust to organism/sensitivities; treat for the appropriate (longer) duration; document CSF sterilization where indicated.

Image & screen for complications

Cranial imaging (ventriculitis, abscess, hydrocephalus, infarction); hearing assessment; developmental follow-up.

⚠ Do-not-miss

HSV meningoencephalitis (aciclovir); ventriculitis/abscess/hydrocephalus; seizures; and inadequate duration/under-dosing.

8. Antibiotics & Duration (Verify Locally)

Principles

Empirical cover per local policy should penetrate the CNS at meningitic doses — commonly a third-generation cephalosporin (e.g., cefotaxime) plus amoxicillin/ampicillin for Listeria, ± an aminoglycoside; add vancomycin for suspected resistant Gram-positives/line infection.
Avoid ceftriaxone in neonates (bilirubin/calcium interactions).
Add aciclovir if HSV is suspected (see 8.3).
Duration is longer than uncomplicated sepsis and organism-dependent (e.g., Gram-negative meningitis typically requires a prolonged course; GBS and Listeria have defined longer courses) — follow local policy; document CSF clearance.

⚠ Verify

Exact agents, meningitic doses, aminoglycoside/vancomycin TDM, and treatment durations must follow the Neonatal Formulary and local antimicrobial policy — flagged for expert review.

9. Complications

Complication	Note
Ventriculitis	Worse outcome; may prolong therapy; image.
Hydrocephalus	May need CSF diversion (see 9.2).
Cerebral abscess/infarction	Especially certain Gram-negatives (e.g., Citrobacter); image.
Seizures	Treat and investigate (see 9.3).
Hearing loss / neurodevelopmental sequelae	Audiology and structured follow-up.

10. Monitoring

Parameter	When	Action
Clinical/neurological status	Continuous	Detect deterioration/seizures; escalate.
Repeat CSF	Where indicated	Document sterilization; guide duration.
Cranial imaging	During/after treatment	Ventriculitis/abscess/hydrocephalus.
Aminoglycoside/vancomycin levels	If used	TDM per policy.
Hearing & development	Follow-up	Detect and support sequelae.

11. Precautions

Safety Cautions

Do not delay antibiotics for the LP in a sick infant — treat first.
A negative blood culture does not exclude meningitis — the CSF is decisive.
Use CNS-penetrating meningitic doses; avoid ceftriaxone in neonates; add aciclovir if HSV suspected.
Treat for the full, longer, organism-specific duration; document CSF sterilization where indicated.
Image for complications and arrange hearing/developmental follow-up.

12. Escalation & Family Support

Family-Centered Communication

"Your baby has an infection of the fluid around the brain. We've started strong antibiotics that reach the brain and taken a spinal-fluid sample to confirm the germ and guide treatment."
"This needs a longer course than a simple infection, and we'll do brain scans and hearing checks to find and treat any complications early."

13. Key Pearls

High-Value Clinical Pearls

Do the LP (unless unsafe) — but never delay antibiotics in a sick baby.
A negative blood culture does not exclude meningitis; CSF is decisive.
Neck stiffness is usually absent — rely on fontanelle, seizures, and consciousness.
Use CNS-penetrating meningitic doses; avoid ceftriaxone; add aciclovir if HSV suspected.
Treat longer and organism-specifically; document CSF sterilization.
Image for ventriculitis/abscess/hydrocephalus; arrange hearing/developmental follow-up.

14. Common Mistakes to Avoid

Mistake	Why it harms	Better practice
Delaying antibiotics for LP.	Worse outcome.	Treat first; LP as soon as safe.
Excluding meningitis on blood culture.	Missed CNS infection.	CSF is decisive; do the LP.
Sepsis-dose/duration for meningitis.	Under-treatment/relapse.	Meningitic doses; longer course.
Using ceftriaxone in neonates.	Bilirubin/calcium risks.	Use cefotaxime; per policy.
No imaging/follow-up.	Missed complications/sequelae.	Image; hearing/developmental follow-up.

15. Board-Style High-Yield Summary

Key Takeaways

Organisms: GBS, E. coli/Gram-negatives, Listeria (early); Gram-negatives/CoNS/S. aureus/Candida (late); HSV (viral).
Presentation non-specific; rely on fontanelle/seizures/consciousness — not neck stiffness.
Do the LP (unless unsafe) but never delay antibiotics; a negative blood culture doesn't exclude meningitis.
Use CNS-penetrating meningitic-dose antibiotics (cefotaxime + amoxicillin/ampicillin ± aminoglycoside; avoid ceftriaxone); aciclovir if HSV suspected.
Treat longer and organism-specifically; document CSF sterilization.
Image for complications (ventriculitis/abscess/hydrocephalus) and arrange hearing/developmental follow-up.

16. References

1.NICE NG195. Neonatal infection: antibiotics for prevention and treatment. 2021. https://www.nice.org.uk/guidance/ng195
2.West Midlands Neonatal ODN. Meningitis; Infection. Neonatal Guidelines 2025–28.
3.AAP. Bacterial meningitis in the neonate — Red Book / clinical guidance (current edition).
4.Baylor College of Medicine. Guidelines for Acute Care of the Neonate, Ed. 33, 2025–2026.
5.Ministry of Health Belize. Neonatal Clinical Practice Guidelines 2018–2021.

Back to Clinical Guideline Hubs

Chapter 8.4 — Neonatal Meningitis